@ClubEffective @D_Bone Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies https://t.co/G6DCpVejrL (N data is on unvaccinated) "Among the RT-PCR-positive subjects, 91% w
@robertopaulos85 @DoctorLunge @BerryTartlet @BreezerGalway @AndyOiseau @MissytheMuse @MichaelYeadon3 @beverleyturner @IggySemz @MrSausager @DrHoenderkamp @BernieSpofforth @ClareCraigPath No it isn't, you either realise that and you are wriggling, or you do
“This article demonstrates that people who have mild COVID-19 illnesses and produce antibodies are protected from reinfection for up to 6 months afterward. The antibodies that people produce in this situation are stable for up to 6 months as well.” https:/
@hansel21_ @Gazbar1980 https://t.co/WBneiqWRRV This study refutes that. Reinfection is not a significant concern.
@hansel21_ @Gazbar1980 Good luck beating the best medical journals out there. https://t.co/5gMDKfGvNx https://t.co/WBneiqWRRV
https://t.co/WBneiqWRRV Reinfection not a risk following a previous infection. Natural Immunity is superior to the mRNA nonsense and the peer reviewed studies show it. Follow the science and make vaccines mimicking natural immunity..you know..traditional
@KHefferon Also, if youre going off hospitalization data, it doesnt tract with peer reviewed studies in addition to Fauci telling you the hospitalization data is skewed. https://t.co/WBneiqWRRV
Articles demonstrates antibody presence post natural infection up to 6 months after. Didn’t test for longer so could be longer. https://t.co/Zm3xbMv5mr
Articles demonstrates antibody presence post natural infection up to 6 months after. Didn’t test for longer so could be longer. https://t.co/Zm3xbMv5mr
RT @atonalmuse: Persistence of antibodies & pseudoviral neutralization for up to 6 mos. after mild SARS-CoV-2. Only 1 subject lost #antibod…
RT @atonalmuse: Persistence of antibodies & pseudoviral neutralization for up to 6 mos. after mild SARS-CoV-2. Only 1 subject lost #antibod…
RT @atonalmuse: Persistence of antibodies & pseudoviral neutralization for up to 6 mos. after mild SARS-CoV-2. Only 1 subject lost #antibod…
RT @atonalmuse: Persistence of antibodies & pseudoviral neutralization for up to 6 mos. after mild SARS-CoV-2. Only 1 subject lost #antibod…
RT @atonalmuse: Persistence of antibodies & pseudoviral neutralization for up to 6 mos. after mild SARS-CoV-2. Only 1 subject lost #antibod…
RT @atonalmuse: Persistence of antibodies & pseudoviral neutralization for up to 6 mos. after mild SARS-CoV-2. Only 1 subject lost #antibod…
RT @atonalmuse: Persistence of antibodies & pseudoviral neutralization for up to 6 mos. after mild SARS-CoV-2. Only 1 subject lost #antibod…
RT @atonalmuse: Persistence of antibodies & pseudoviral neutralization for up to 6 mos. after mild SARS-CoV-2. Only 1 subject lost #antibod…
RT @atonalmuse: Persistence of antibodies & pseudoviral neutralization for up to 6 mos. after mild SARS-CoV-2. Only 1 subject lost #antibod…
RT @atonalmuse: Persistence of antibodies & pseudoviral neutralization for up to 6 mos. after mild SARS-CoV-2. Only 1 subject lost #antibod…
RT @atonalmuse: Persistence of antibodies & pseudoviral neutralization for up to 6 mos. after mild SARS-CoV-2. Only 1 subject lost #antibod…
Persistence of antibodies & pseudoviral neutralization for up to 6 mos. after mild SARS-CoV-2. Only 1 subject lost #antibodies between visits. 2nd visit 300 days after. We're continuing #study to evaluate whether additional subjects lose antibody respo
4,448/ Michigan, USA (adult smoking rate was 18.9% in 2019) smoker: C=current, F=former Of 653 health care workers & patients with a high risk of exposure to COVID-19, C=2.6% & F=15% 338 tested: C=3.6% & F=19.2% 129 positive: C=2.3% &
RT @2dedostesta2: “This article demonstrates that people who have mild COVID-19 illnesses and produce antibodies are protected from reinfec…
“This article demonstrates that people who have mild COVID-19 illnesses and produce antibodies are protected from reinfection for up to 6 months afterward.” https://t.co/zPyxQALtSu
RT @Vaccinologist: In the past, it was thought that only severe illness could produce strong #antibody responses to infection. This NEW stu…
RT @Vaccinologist: In the past, it was thought that only severe illness could produce strong #antibody responses to infection. This NEW stu…
RT @Vaccinologist: In the past, it was thought that only severe illness could produce strong #antibody responses to infection. This NEW stu…
RT @Vaccinologist: In the past, it was thought that only severe illness could produce strong #antibody responses to infection. This NEW stu…
RT @Vaccinologist: In the past, it was thought that only severe illness could produce strong #antibody responses to infection. This NEW stu…
@Andwet1 @AllahnBallahn @JuliaCaesar08 Skulle inte säga att intresset för det är svagt alls. Här är en bunt studier: https://t.co/E3GnYxCTmL https://t.co/alFwCqJFAm https://t.co/ONEEDQSALR https://t.co/ghXcf1CKEq https://t.co/anLGsT4Ukz https://t.co/
RT @Vaccinologist: In the past, it was thought that only severe illness could produce strong #antibody responses to infection. This NEW stu…
RT @Vaccinologist: In the past, it was thought that only severe illness could produce strong #antibody responses to infection. This NEW stu…
RT @Vaccinologist: In the past, it was thought that only severe illness could produce strong #antibody responses to infection. This NEW stu…
RT @Vaccinologist: In the past, it was thought that only severe illness could produce strong #antibody responses to infection. This NEW stu…
RT @Vaccinologist: In the past, it was thought that only severe illness could produce strong #antibody responses to infection. This NEW stu…
RT @Vaccinologist: In the past, it was thought that only severe illness could produce strong #antibody responses to infection. This NEW stu…
RT @Vaccinologist: In the past, it was thought that only severe illness could produce strong #antibody responses to infection. This NEW stu…
RT @Vaccinologist: In the past, it was thought that only severe illness could produce strong #antibody responses to infection. This NEW stu…
This is good news, even for us who were exposed sa covid.
In the past, it was thought that only severe illness could produce strong #antibody responses to infection. This NEW study suggests there is longer-term immunity even from a mild infection. But still #GetVaccinated after #infection, HYBRID #immunity is 👌🏻
RT @markvanasten: "Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutr…
"Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies" https://t.co/GpUpxGF4Xz
Recovery from [mild] Covid-19 and protection from future SARS2-CoV2 infection remains unanswered. A new study sheds light on antibody production after recovery: https://t.co/SE6dUITWsE
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies | Microbiology Spectrum https://t.co/SnWldWYM7M
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies https://t.co/Wv8dqwKRwn #COVID19 #MILD #infection #antibodies https://t.co/ahYtU0ur5J